artículo académico

• Persistence of Immunity When Using Different Human Papillomavirus Vaccination Schedules and Booster-Dose Effects 5 Years After Primary Vaccination .  Journal of Infectious Diseases.  219:41-49. 2019
• Evaluation of the immunogenicity of the quadrivalent HPV vaccine using 2 versus 3 doses at month 21: An epidemiological surveillance mechanism for alternate vaccination schemes.  Journal Human Vaccines & Immunotherapeutics.  12:30-38. 2015